1.A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity.
Min SONG ; Hyunhee DO ; Oh Kwang KWON ; Eun Ju YANG ; Jong Sup BAE ; Tae Cheon JEONG ; Kyung Sik SONG ; Sangkyu LEE
Biomolecules & Therapeutics 2014;22(2):155-160
Thelephoric acid is an antioxidant produced by the hydrolysis of polyozellin, which is isolated from Polyozellus multiplex. In the present study, the inhibitory effects of polyozellin and thelephoric acid on 9 cytochrome P450 (CYP) family members (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) were examined in pooled human liver microsomes (HLMs) using a cocktail probe assay. Polyozellin exhibited weak inhibitory effects on the activities of all 9 CYPs examined, whereas thelephoric acid exhibited dose- and time-dependent inhibition of all 9 CYP isoforms (IC50 values, 3.2-33.7 muM). Dixon plots of CYP inhibition indicated that thelephoric acid was a competitive inhibitor of CYP1A2 and CYP3A4. In contrast, thelephoric acid was a noncompetitive inhibitor of CYP2D6. Our findings indicate that thelephoric acid may be a novel, non-specific CYP inhibitor, suggesting that it could replace SKF-525A in inhibitory studies designed to investigate the effects of CYP enzymes on the metabolism of given compounds.
Cytochrome P-450 CYP1A2
;
Cytochrome P-450 CYP2D6
;
Cytochrome P-450 CYP2E1
;
Cytochrome P-450 Enzyme System*
;
Humans
;
Hydrolysis
;
Metabolism
;
Microsomes, Liver
;
Proadifen*
;
Protein Isoforms
2.Effects of Gukang Capsules on activity and protein expression of hepatic cytochrome P450 enzymes in rats.
Chang YANG ; Jing LI ; Jia SUN ; Ding-Yan LU ; Shuai-Shuai CHEN ; Yong-Jun LI ; Yong-Lin WANG ; Ting LIU
China Journal of Chinese Materia Medica 2022;47(21):5936-5943
Gukang Capsules are often used in combination with drugs to treat fractures, osteoarthritis, and osteoporosis. Cytochrome P450(CYP450) mainly exists in the liver and participates in the oxidative metabolism of a variety of endogenous and exogenous substances and serves as an important cause of drug-metabolic interactions and adverse reactions. Therefore, it is of great significance to study the effect of Gukang Capsules on the activity and expression of CYP450 for increasing its clinical rational medication and improving the safety of drug combination. In this study, the Cocktail probe method was used to detect the changes in the activities of CYP1A2, CYP3A2, CYP2C11, CYP2C19, CYP2D4, and CYP2E1 in rat liver after treatment with high-, medium-and low-dose Gukang Capsules. The rat liver microsomes were extracted by the calcium chloride method, and protein expression of the above six CYP isoform enzymes was detected by Western blot. The results showed that the low-dose Gukang Capsules could induce CYP3A2 and CYP2D4 in rats, medium-dose Gukang Capsules had no effect on them, and high-dose Gukang Capsules could inhibit them in rats. The high-dose Gukang Capsules did not affect CYP2C11 in rats, but low-and medium-dose Gukang Capsules could induce CYP2C11 in rats. Gukang Capsules could inhibit CYP2C19 in rats and induce CYP1A2 in a dose-independent manner, but did not affect CYP2E1. If Gukang Capsules were co-administered with CYP1A2, CYP2C19, CYP3A2, CYP2C11, and CYP2D4 substrates, the dose should be adjusted to avoid drug interactions.
Rats
;
Animals
;
Cytochrome P-450 CYP1A2/metabolism*
;
Cytochrome P-450 CYP2C19
;
Cytochrome P-450 CYP2E1/pharmacology*
;
Rats, Sprague-Dawley
;
Cytochrome P-450 Enzyme System/metabolism*
;
Microsomes, Liver
;
Liver
;
Cytochrome P-450 CYP3A/metabolism*
3.Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19.
Acta Pharmaceutica Sinica 2007;42(1):8-12
Flavonoids are present in fruits, vegetables and beverages derived from plants, and in many dietary supplements or herbal remedies. A number of naturally occurring flavonoids have been shown to modulate the CYP450 system, including the induction or inhibition of these enzymes. This review focuses on the flavonoid effects on cytochrome P450 (CYP) enzyme CYP1, 2E1, 3A4 and 19. Flavonoids alter CYPs by various mechanisms, including the stimulation of gene expression via specific receptors and/or CYP protein, or mRNA stabilization and so on. But in vivo and in vitro, the effects of flavonoids are not always coincident as a result of concentrations of flavonoids, genetic and environmental factors. As well, flavonoids may interact with drugs through the induction or inhibition of their metabolism. Much attention should be paid to the metabolism interaction of the flavonoids when coadministered with other drugs.
Animals
;
Aromatase
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A1
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1 Inhibitors
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Enzyme Activation
;
drug effects
;
Flavonoids
;
pharmacology
;
Humans
;
RNA, Messenger
;
genetics
;
metabolism
4.Induction of rat hepatic CYP2E1 expression by arecoline in vivo.
Xiang-tao HUANG ; Run-mei XIAO ; Ming-feng WANG ; Jun-jun WANG ; Yong CHEN
Acta Pharmaceutica Sinica 2016;51(1):153-156
The regulation mechanism of arecoline on rat hepatic CYP2E1 was studied in vivo. After oral administration of arecoline hydrobromide (AH; 4, 20 and 100 mg x kg(-1) x d(-1)) to rats for one week, the hepatic CYP2E1 mRNA level remained unchanged, but the hepatic CYP2E1 protein content was dose-dependently increased. Additionally, although the hepatic CYP2E1 activity was induced by AH treatment, the induction was attenuated with the increase in dosage. The results indicate that the effect of arecoline on rat hepaticdoes not involve transcriptional activation of the gene, but largely involves the stabilization of CYP2E1 protein against degradation or increased efficiency of CYP2E1 mRNA translation, and additionally involve the post- ranslational modification of CYP2E1 protein. Furthermore, the CYP2E1 response is fairly equal among the different species, the induction of rat hepatic CYP2E1 by arecoline suggests that there is a risk of metabolic interaction among the substrate drugs of CYP2E1 in betel-quid use human.
Animals
;
Arecoline
;
pharmacology
;
Cytochrome P-450 CYP2E1
;
metabolism
;
Cytochrome P-450 CYP2E1 Inducers
;
pharmacology
;
Humans
;
Liver
;
drug effects
;
metabolism
;
RNA, Messenger
;
Rats
5.Anti-oxidant activities of kiwi fruit extract on carbon tetrachloride-induced liver injury in mice.
Wonyoung KANG ; Heekyoung YANG ; Hyun Ju HONG ; Chang Hoon HAN ; Young Jae LEE
Korean Journal of Veterinary Research 2012;52(4):275-280
The kiwi (Actinidia deliciosa) is well known to contain anti-oxidants. In this study, we investigated the anti-oxidant effects of kiwi extract on carbon tetrachloride (CCl4) induced liver injury in BALB/c mice. The radical scavenging effect of 80% methanol extract of Halla-Gold kiwi was observed. For the animal study, mice were randomly divided into four groups: normal group, CCl4-induced model group, kiwi extract administered group, and silymarin treated group. The kiwi extract was provided daily for 10 days. At the 24 h after last administration, CCl4 was injected. The kiwi extract showed strong inhibitory effect of DPPH radicals and superoxide scavenging. In animal study, administration of CCl4 resulted in significantly elevated plasma levels of ALT and AST but they decreased in kiwi-extract pretreated group. Anti-oxidant enzymes such as GSH-px and GSH-rd were restored in the kiwi extract treatment group. Histopathological degeneration was also prevented in the kiwi extract treated group compared with of the control group, which exhibited CCl4-induced hepatotoxicity. On the basis of the obtained results, it can be concluded that kiwi extract showed protective effects, not only as anti-oxidant effects, but also in the protection of hepatotoxicity in CCl4-intoxicated mice.
Animals
;
Antioxidants
;
Carbon
;
Carbon Tetrachloride
;
Cytochrome P-450 CYP2E1
;
Fruit
;
Liver
;
Methanol
;
Mice
;
Plasma
;
Silymarin
;
Superoxides
7.Effect of hepatocyte cytochrome P450 2E1 gene and its expression in nonalcoholic steatosis in rats.
Hong-Tao SHI ; Dong-Feng CHEN ; Tao LI ; Ren-Ping XIONG
Chinese Journal of Hepatology 2005;13(2):154-155
Animals
;
Cytochrome P-450 CYP2E1
;
biosynthesis
;
genetics
;
Fatty Liver
;
genetics
;
Liver
;
metabolism
;
Male
;
Rats
;
Rats, Wistar
10.Hepatotoxicity in Rats Treated with Dimethylformamide or Toluene or Both.
Ki Woong KIM ; Yong Hyun CHUNG
Toxicological Research 2013;29(3):187-193
The effects of toluene in dimethylformamide (DMF)-induced hepatotoxicity were investigated with respect to the induction of cytochrome P-450 (CYP) and the activities of related enzymes. The rats were treated intraperitoneally with the organic solvents in olive oil (Single treatment groups: 450 [D1], 900 [D2], 1,800 [D3] mg DMF, and 346 mg toluene [T] per kg of body weight; Combined treatment groups: D1+T, D2+T, and D3+T) once a day for three days, while the control group received just the olive oil. Each group consisted of 4 rats. The activities of the xenobiotic metabolic enzymes and the hepatic morphology were assessed. The immunoblots indicated that the expression of CYP2E1 was considerably enhanced depending on the dosage of DMF and the CYP2E1 blot densities were significantly increased after treatment with both DMF and toluene, compared to treatment with DMF alone. The activities of glutathione-S-transferase and glutathione peroxidase were either decreased or remained unaltered after treatment with DMF and toluene, whereas the lipid peroxide levels were increased with increasing dosage of DMF and toluene. The liver tissue in the D3 group (1,800 mg/kg of DMF) showed signs of microvacuolation in the central vein region and a large necrotic zone around the central vein, in rats treated with both DMF (1,800 mg/kg) and toluene (D3T). These results suggest that the expression of CYP2E1 is induced by DMF and enhanced by toluene. These changes may have facilitated the accelerated formation of N-methylformamide (NMF) from toluene, and the generated NMF may directly induce liver damage.
Animals
;
Body Weight
;
Cytochrome P-450 CYP2E1
;
Cytochrome P-450 Enzyme System
;
Dimethylformamide*
;
Formamides
;
Glutathione Peroxidase
;
Lipid Peroxides
;
Liver
;
Olea
;
Plant Oils
;
Rats*
;
Solvents
;
Toluene*
;
Veins
;
Olive Oil